SOURCE: Industrial Info Resources

Industrial Info Resources

November 05, 2015 06:30 ET

Texas Round-Up: Lone Star State Ropes in More Than $4 Billion in Active Capital Project Investment From Pharmaceutical-Biotech Sector, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Nov 5, 2015) - Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--While more commonly known as the land where oil and chemical industry workers roam, Texas is steadily becoming home to a growing number of scientists from the pharmaceutical and biotech fields. A recent survey of all active capital projects within the state, and sourced from the sector, revealed a healthy mix of 56 public and private projects with a staggering total investment value (TIV) of $4.15 billion.

Within this article: Details on pharmaceutical and biotech projects in Texas, including those from companies such as GlaxoSmithKline (NYSE:GSK) and Lonza Group.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch